Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer
Ruijin Hospital
Ruijin Hospital
Weill Medical College of Cornell University
National University Hospital, Singapore
NuCana plc
Ukrainian Society of Clinical Oncology
Columbia University
Spanish Lung Cancer Group
The Christie NHS Foundation Trust
Karolinska University Hospital
UNICANCER
Memorial Sloan Kettering Cancer Center
University of Kentucky
University of Turin, Italy
Baylor Breast Care Center
Sun Yat-sen University
University of Colorado, Denver
Shanghai University of Traditional Chinese Medicine
Tampere University Hospital
Georgetown University
Ohio State University Comprehensive Cancer Center
NYU Langone Health
University of Pittsburgh
University of Kansas Medical Center
Hellenic Oncology Research Group
New Mexico Cancer Research Alliance
University of Pittsburgh
Bastyr University
University Hospital of Crete
Hellenic Oncology Research Group
H. Lee Moffitt Cancer Center and Research Institute
Washington University School of Medicine
Shenyang Pharmaceutical University
University of Southern California
Groupe Francais De Pneumo-Cancerologie
Clinica Universidad de Navarra, Universidad de Navarra
Baylor Breast Care Center
Hellenic Oncology Research Group
Hellenic Oncology Research Group
Baylor Breast Care Center
M.D. Anderson Cancer Center
Baylor Breast Care Center
Providence Health & Services
Case Comprehensive Cancer Center
Rabin Medical Center
SCRI Development Innovations, LLC
Hellenic Oncology Research Group
Georgia Center for Oncology Research & Education